Last ¥7,080 JPY
Change Today -120.00 / -1.67%
Volume 26.0K
4534 On Other Exchanges
Symbol
Exchange
Tokyo
Frankfurt
As of 2:00 AM 08/22/14 All times are local (Market data is delayed by at least 15 minutes).

mochida pharmaceutical co (4534) Snapshot

Open
¥7,180
Previous Close
¥7,200
Day High
¥7,200
Day Low
¥7,050
52 Week High
04/1/14 - ¥7,580
52 Week Low
12/25/13 - ¥5,678
Market Cap
155.1B
Average Volume 10 Days
18.3K
EPS TTM
¥490.29
Shares Outstanding
21.9M
EX-Date
09/26/14
P/E TM
14.4x
Dividend
¥150.00
Dividend Yield
2.26%
Current Stock Chart for MOCHIDA PHARMACEUTICAL CO (4534)

Related News

No related news articles were found.

mochida pharmaceutical co (4534) Related Businessweek News

No Related Businessweek News Found

mochida pharmaceutical co (4534) Details

Mochida Pharmaceutical Co., Ltd. produces and sells pharmaceuticals, diagnostic reagents, medical devices, and skin care products in Japan. It provides cardiovascular agents comprising Epadel for arteriosclerosis obliterans and hyperlipidemia; Atelec and Atedio for hypertension; and Rocornal for angina pectoris, as well as analgesic agents, including Tramcet for chronic pain and tooth extraction pain. The company also offers antidiabetes agents, such as Fastic for diabetes; neurological agents, including Lexapro and Tecipul for depression, and Grandaxin for autonomic dystonia; and anti-infectives, such as Florid for mycosis, Isoprinosine for subacute sclerosing panencephalitis, Beselna for condyloma acuminatum, and Francetin, an antibiotic, as well as Arasena-A for herpes zoster, herpes simplex, and herpes simplex encephalitis. In addition, it provides hormone preparations comprising Dinagest for endometriosis; Divigel for menopausal symptoms; Suprecur for endometriosis, precocious puberty, and uterine myoma; Desopan, an antiadrenal cortical hormone; Ortho 777-21/M-21, an oral contraceptive; Estriel for hormone replacement therapy and osteoporosis; and HCG Mochida, a human chorionic gonadotrophin injection. Further, the company offers biological preparations, such as Miraclid for acute circulatory failure and pancreatitis; Thrombin, a hemostatic agent; Novo-Heparin for thrombosis; and Uronase for acute myocardial infarction. Additionally, it provides diagnostic reagents for fertility/infertility, as well as CanD-Tec, a candida antigen detection test; face and body care, and hair care products; biosimilars and nutraceuticals; baby care products comprising bath oils, skin cleansers, and shampoos; and contract manufacturing services. Mochida Pharmaceutical Co., Ltd. was founded in 1913 and is headquartered in Tokyo, Japan.

1,726 Employees
Last Reported Date: 06/27/14
Founded in 1913

mochida pharmaceutical co (4534) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

mochida pharmaceutical co (4534) Key Developments

Mochida Pharmaceutical Co. Ltd. to Report Q1, 2015 Results on Jul 28, 2014

Mochida Pharmaceutical Co. Ltd. announced that they will report Q1, 2015 results on Jul 28, 2014

Mochida Pharmaceutical Co. Ltd., Annual General Meeting, Jun 27, 2014

Mochida Pharmaceutical Co. Ltd., Annual General Meeting, Jun 27, 2014.

Mochida Pharmaceutical Co. Ltd., 2014 Earnings Call, May 15, 2014

Mochida Pharmaceutical Co. Ltd., 2014 Earnings Call, May 15, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4534:JP ¥7,080.00 JPY -120.00

4534 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4534.
View Industry Companies
 

Industry Analysis

4534

Industry Average

Valuation 4534 Industry Range
Price/Earnings 14.3x
Price/Sales 1.5x
Price/Book 1.5x
Price/Cash Flow 15.6x
TEV/Sales 1.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MOCHIDA PHARMACEUTICAL CO, please visit www.mochida.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.